Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 5;11(11):CD009561.
doi: 10.1002/14651858.CD009561.pub2.

Artificial corneas versus donor corneas for repeat corneal transplants

Affiliations

Artificial corneas versus donor corneas for repeat corneal transplants

Esen K Akpek et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: Individuals who have failed one or more full thickness penetrating keratoplasties (PKs) may be offered repeat corneal surgery using an artificial or donor cornea. An artificial or prosthetic cornea is known as a keratoprosthesis. Both donor and artificial corneal transplantations involve removal of the diseased and opaque recipient cornea (or the previously failed cornea) and replacement with another donor or prosthetic cornea.

Objectives: To assess the effectiveness of artificial versus donor corneas in individuals who have had one or more failed donor corneal transplantations.

Search methods: We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (2013, Issue 10), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to November 2013), EMBASE (January 1980 to November 2013), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to November 2013), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (www.clinicaltrials.gov) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 27 November 2013.

Selection criteria: Two review authors independently assessed reports from the electronic searches to identify randomized controlled trials (RCTs) or controlled clinical trials (CCTs). We resolved discrepancies by discussion or consultation with a third review author.

Data collection and analysis: For discussion purposes, we assessed findings from observational cohort studies and non-comparative case series. No data synthesis was performed.

Main results: We did not identify any RCTs or CCTs comparing artificial corneas with donor corneas for repeat corneal transplantations.

Authors' conclusions: The optimal management for those individuals who have failed a conventional corneal transplantation is not known. Currently, in some centers, artificial corneal devices routinely are recommended after just one graft failure, and in others, not until after multiple graft failures, or not at all. To date, there have been no controlled trials comparing the visual outcomes and complications of artificial corneal devices (particularly the Boston type 1 keratoprosthesis which is the most commonly implanted artificial corneal device) with repeat donor corneal transplantation, in order to guide surgeons and their patients. It is apparent that such a trial is needed and would offer significant benefit to an ever-increasing pool of people with visual disability due to corneal opacification, most of whom are still in productive stages of their lives.

PubMed Disclaimer

Conflict of interest statement

DECLARATIONS OF INTEREST

None known.

Figures

Figure 1
Figure 1. Results for searching for studies for inclusion in the review

References

References to studies excluded from this review

    1. Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116(4):640–51. - PubMed
    1. Aldave AJ, Sangwan VS, Basu S, Basak SK, Hovakimyan A, Gevorgyan O, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012;119(8):1530–8. - PubMed
    1. Goldman DR, Hubschman JP, Aldave AJ, Chiang A, Huang JS, Bourges JL, et al. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina. 2013;33(3):532–41. - PubMed
    1. Kim MJ, Yu F, Aldave AJ. Microbial keratitis after Boston type I keratoprosthesis implantation: incidence, organisms, risk factors, and outcomes. Ophthalmology. 2013;120(11):2209–16. - PubMed
    1. Sejpal K, Yu F, Aldave AJ. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea. 2011;30(11):1187–94. - PubMed

Additional references

    1. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern® Guidelines. [6 February 2014];Corneal edema and opacification. www.aao.org/ppp.
    1. The Australian Corneal Graft Registry. 1990 to 1992 report. Australian and New Zealand Journal of Ophthalmology. 1993;21(2 Suppl):1–48. - PubMed
    1. Ament JD, Stryjewski TP, Ciolino JB, Todani A, Chodosh J, Dohlman CH. Cost-effectiveness of the Boston keratoprosthesis. American Journal of Ophthalmology. 2010;149(2):221–8. - PubMed
    1. Bersudsky V, Blum-Hareuveni T, Rehany U, Rumelt S. The profile of repeated corneal transplantation. Ophthalmology. 2001;108(3):461–9. - PubMed
    1. Eye Bank Association of America. [3 February 2014];2013 Eye banking statistical report. www.restoresight.org/wp-content/uploads/2014/04/2013Statistical.Report-F....

References to other published versions of this review

    1. Akpek EK, Alkharashi M, Lindsley K. Artificial corneas versus donor corneas for repeat corneal transplants. Cochrane Database of Systematic Reviews. 2012;(1) doi: 10.1002/14651858.CD009561. Indicates the major publication for the study. - DOI - PMC - PubMed

Publication types

LinkOut - more resources